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Flap endonuclease 1 (FEN1) andDna2 endonuclease/helicase
(Dna2) sequentially coordinate their nuclease activities for effi-
cient resolution of flap structures that are created during the
maturation of Okazaki fragments and repair of DNA damage.
Acetylation of FEN1 by p300 inhibits its endonuclease activity,
impairing flap cleavage, a seemingly undesirable effect.We now
show that p300 also acetylates Dna2, stimulating its 5–3 endo-
nuclease, the 5–3helicase, andDNA-dependentATPase activ-
ities. Furthermore, acetylated Dna2 binds its DNA substrates
with higher affinity. Differential regulation of the activities of
the two endonucleases by p300 indicates a mechanism in which
the acetylase promotes formationof longer flaps in the cell at the
same time as ensuring correct processing. Intentional formation
of longer flapsmediatedbyp300 in an active chromatin environ-
ment would increase the resynthesis patch size, providing
increased opportunity for incorrect nucleotide removal during
DNA replication and damaged nucleotide removal during DNA
repair. For example, altering the ratio between short and long
flap Okazaki fragment processing would be a mechanism for
better correction of the error-prone synthesis catalyzed byDNA
polymerase .
Eukaryotic DNA is tightly compacted into the nucleus with
the help of histone proteins that form chromatin, consequen-
tially making the DNA less accessible to the various biological
machineries that process its genetic information. DNA replica-
tion and repair are complex processes involving the assembly
and coordinated function of a multitude of proteins. The lim-
ited accessibility of the chromatin environment to these pro-
teins provides a challenge to their efficient operation. Chroma-
tin-remodeling enzymes such as histone acetyltransferases play
a significant role in modifying the structure of the chromatin
during various biological activities. SV40 replication in vitrohas
been shown to occur with higher frequency in minichromo-
somes that contain hyperacetylated histones, indicating easier
access and movement of the replisome on the nucleosomal
DNA (1).
In addition tomodifying histones, the acetyltransferase p300
also interacts with and acetylates many nonhistone proteins.
Proliferating cell nuclear antigen (PCNA),4 a vital component
of DNA replication and repair machinery, recruits p300 to the
DNA, where it likely acetylates histone proteins in preparation
for replication or repair (2). Significantly, PCNA is acetylated by
p300, and the modification increases PCNA binding efficiency
to the main polymerase involved in Okazaki fragment matura-
tion, DNA polymerase  (3). In addition to modifying PCNA,
p300 also acetylates many proteins involved in base excision
repair such asDNApolymerase, apurinic/apyrimidinic endo-
nuclease 1, and DNA glycosylases, modifying their enzymatic
functions (4–6).
Current work suggests that Okazaki fragment processing
and long patch base excision repair involve stranddisplacement
synthesis that creates flaps for the removal of priming RNA/
DNA in replication and damage in repair (7, 8). In most cases,
flap endonuclease 1 (FEN1) cleaves the flaps while short; how-
ever, there is a potential for some flaps, which escape FEN1
cleavage, to exceed 20 nt in length (9, 10). These longer flaps are
coated by replication protein A (RPA), inhibiting FEN1 and
creating the requirement for the Dna2 nuclease/helicase
(Dna2). RPA stimulates Dna2, which displaces RPA and cleaves
the flap to a length of 5–6 nt, allowing FEN1 access (11–13).
This is known as the “two-nuclease” Okazaki processing path-
way. Dna2, the second endonuclease, is a multifunctional pro-
tein possessing 5–3, 3–5 endonuclease activity, ATPase
activity, and limited helicase activity (14, 15). Many biochemi-
cal and genetic studies have shown that Dna2 and FEN1 inter-
act and have sequential functions in processing flap substrates
(16).
FEN1 plays a central role in essential cellular functions
including Okazaki fragment maturation (8), long patch base
excision repair (17), and nonhomologous end joining (18).
FEN1 is also posttranslationally modified after forming a com-
plex with p300 in vitro and in vivo (19). Acetylation inhibits
FEN1 exo- and endonuclease activities and also reduces its
DNA binding efficiency (19, 20). Inactivation or haploinsuffi-
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ciency of FEN1 has been previously linked to increased tumor
formation and rapid progression to cancer (21, 22). Therefore,
the finding that acetylation of FEN1 reduces its activity has
been difficult to rationalize physiologically because it is a vital
endonuclease in various DNA metabolic processes.
Previously, it was proposed that FEN1 acetylation inhibits its
enzymatic function to avoid the premature processing of Oka-
zaki fragments (19). Inhibition of FEN1would promote the for-
mation of longer flaps requiring the two-nuclease pathway.
Because acetylation of FEN1 should promote utilization of
Dna2, we considered the possibility thatDna2 is also acetylated,
allowing it to accommodate a greater flowof substrates through
the two-nuclease pathway. In this study, we examined whether
Dna2 could be acetylated, the biochemical effects of such a
modification, and the likely regulatory effects in the cell.
EXPERIMENTAL PROCEDURES
Oligonucleotides—Synthetic oligonucleotides were synthe-
sized by Integrated DNA Technologies and subjected to 3 end
labeling as described previously (23). The 53-nt flap substrate,
32P-labeled on the 3 end of the downstream primer, was used
to study 5–3 nuclease activity and binding efficiency of Dna2.
Thesubstrate sequenceandannealingconditionswere thesameas
those described previously (11). The helicase assay was measured
using a substrate that contained a 32P-labeled 5, 42-base oligonu-
cleotide annealed to M13mp18 ssDNA (New England Biolabs),
resulting in apartial duplex substratewith an18-nt 5noncomple-
mentary strand as described previously (15).
Purified Proteins—hDna2 (15)and hFEN1 (24) were purified
as described previously. Full-length recombinant p300 (31124)
and recombinant catalytic domain mapping amino acids 965–
1810 (31205) were purchased from Active Motif. Recombinant
catalytic domain mapping 1284–1673 (SE451-0100) was pur-
chased from Biomol International.
In Vitro Acetylation—Two micrograms of purified hDna2
was incubated with 0.1 Ci of [14C]acetyl coenzyme A
(PerkinElmer Life Sciences) in 20 l of histone acetyltrans-
ferase buffer (50 mM Tris-HCl (pH 8.0), 10% (v/v) glycerol, 150
mMNaCl, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl flu-
oride, 10 mM sodium butyrate) for 30 min at 30 °C along with
100 ng of either the recombinant full-length or the catalytic
domain of p300 (Active Motif). The catalytic domain was used
for acetylating Dna2 used in vitro. The acetylated and unacety-
lated formswere separated on a 4–15%SDS-polyacrylamide gel
(Bio-Rad). The gels were subjected to Coomassie stain, dried in
a vacuum, and then subjected to autoradiography.
Binding Assay—Purified Dna2 (1 ng) and 1 ng of either the
catalytic domains (965–1810 or 1284–1673) or 1 ng of full-
length p300 were allowed to bind together in a coupling buffer
consisting of 25 mM HEPES (pH7.5), 100 mM NaCl, 1 mM
EDTA, 1mM dithiothreitol, and 10% glycerol for 2h at 4 °C (in a
1:1 ratio). Antibody to p300 (Santa Cruz Biotechnology (SCBT)
sc-585 or sc-32244) and control IgG (SCBT sc-2027) were pre-
bound to protein A-agarose for 1 h at room temperature and
washed twice with phosphate-buffered saline. The bound pro-
teins were then added to the washed protein A-agarose-anti-
body complex and incubated overnight at 4 °C with end-over
mixing. The following day, the proteins were released from the
protein A-agarose using elution buffer. The immunoprecipi-
tates were separated on precast 10% gels (Bio-Rad). Western
blot analysis was performed with anti-Dna2 polyclonal anti-
body (Abcam 42439).
Co-Immunoprecipitation—Immunoprecipitation was per-
formed using the protocol described in the Roche immunopre-
cipitation kit (117193934001) with minor modifications.
Untreated and UV-treated HeLa whole cell extracts were pre-
cleared using Preclearing Matrix B-rabbit (SCBT sc-45059) or
Preclearing Matrix B-goat (sc-45053) depending on the anti-
body thatwas used to immunoprecipitate the protein. Antibod-
ies to Dna2, p300, or control IgG were prebound to protein
A-agarose for 1 h at room temperature and washed twice with
phosphate-buffered saline. The precleared lysate was then
added to the washed protein A-agarose-antibody complex and
incubated overnight at 4 °C with end-over mixing. The follow-
ing day the proteins were released from the protein A-agarose
using elution buffer. The immunoprecipitates were separated
on precast 10% gels (Bio-Rad). Western blot analysis was per-
formed with anti-Dna2 antibody (Abcam 42439), anti-p300
antibody (SCBT sc-584), anti-FEN1 antibody (Abcam ab17993),
and anti-acetylated lysine antibody (Cell Signaling 9441).
Nuclease Assay—Five fmol of substrate (53-nt flap substrate)
labeled at the 3 end of the downstream primer was incubated
with various amounts of proteins, as indicated in a reaction
volume of 20 l, at 37 °C for 10 min. The reaction buffer con-
sisted of 50 mM Tris-HCl (pH 8.0), 2 mM dithiothreitol, 30 mM
NaCl, 0.1mg/ml bovine serumalbumin, 2mMMgCl2, and 1mM
ATP. The reactions were terminated using 2 termination dye
(90% formamide (v/v), 10 mm EDTA, 0.01% bromphenol blue,
and 0.01% xylene cyanol). After termination, samples were
heated at 95 °C for 5 min and loaded onto a denaturing gel (7 M
urea) 15% polyacrylamide gel and electrophoresed for 1 h 30
min at 3000 V.
Helicase Assay—Helicase assay was performed using the
nuclease-deficient mutant of hDna2 (D294A). The helicase
substrate was incubated with various amounts of proteins, as
indicated in a reaction volume of 20l, at 37 °C for 60min. The
reaction buffer consisted of 50 mM Tris-HCl (pH 7.5), 25 mM
NaCl, 2mMdithiothreitol, 0.25mg/ml bovine serum albumin, 4
mM MgCl2, 4 mM ATP. The reactions were terminated using
5 stop solution (60 mM EDTA, 40% sucrose, 0.6% SDS, 0.25%
bromphenol blue, and 0.25% xylene cyanol). After termination,
samples were loaded on an 8% native polyacrylaminde gel and
electrophoresed for 1 h at 150 V.
ATPase Assay—ATPase reactions were performed as
described previously (15). The reactionswere incubatedwith or
without 1 g of oligonucleotide (ssDNA, 30 bases) for 30 min
and stopped by 10mMEDTA/10% acid-washed charcoal (Norit
Protocol). The reactions were allowed to sit on ice overnight
and spun at 13,000 rpm for 30min the following day. Duplicate
100-l supernatant samples were counted by the Cerenkov
method. ATP hydrolysis was determined by dividing the
adjusted protein-dependent counts by the specific activity of
ATP in each reaction.
ElectrophoreticMobility Gel Shift Assays—Binding efficiency
of unacetylated and acetylated Dna2 to a 53 nt flap substrate
was assessed using electrophoreticmobility gel shift assays. Five
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fmol of substrate was incubated with increasing concentrations
(10, 20, and 50 fmol) of either of Dna2 alone, Dna2, and p300
and acetylated Dna2 (Ac-Dna2) and incubated for 10 min at
room temperature in a reaction buffer consisting of 50mMTris-
HCl (pH 8.0), 2 mM dithiothreitol, 30 mM NaCl, 0.1 mg/ml
bovine serum albumin, and 5% glycerol. The reactions were
loaded on prerun 6% polyacrylamide gels in 0.5 Tris-borate
EDTA (TBE) buffer (Invitrogen). Gels were subjected to elec-
trophoresis for 30–45 min at constant 150 V.
RESULTS
hDna2 Is Acetylated inVitro and inVivo—Tounderstand the
cellular rationale for inhibition of FEN1, we initially investi-
gatedwhether its functional interacting partner, Dna2, was also
affected by acetylation. Either the full-length p300 or the cata-
lytic (acetyltransferase) domain of p300 was incubated with
purified Dna2 and [14C]acetyl coenzyme A. Similar to FEN1,
the purified Dna2 protein was robustly acetylated in vitro by
both full-length p300 and the catalytic domain of p300 (Fig. 1A,
lane 2). To confirm the association of p300 and Dna2 in vitro,
binding assays using the purified human recombinant proteins
were performed.Dna2 and either full-length p300 or truncation
mutants, 1284–1673 or 965–1810, of p300 containing the
catalytic domains were incubated
together. Using an antibody that
recognizes the full-length p300
and the different length catalytic
domains, an immunoprecipitation
was performed to assess Dna2 bind-
ing to the different forms of p300.
The immunoprecipitates were sep-
arated on a SDS-polyacrylamide gel,
and Western blotting was per-
formed using antibody against
Dna2. The nonspecific IgG showed
no contamination with Dna2 (Fig.
1B, lane 2). Both the 1284–1673
(Fig. 1B, lane 3) and 965–1810 (Fig.
1B, lane 4) p300 catalytic domains
were as efficient at binding Dna2 as
full-length p300 (Fig. 1B, lane 5).
The association of the purified pro-
teinswas notmediated byDNA, and
a molar excess of purified FEN1 in
the assay did not abrogate the bind-
ing between Dna2 and p300 (data
not shown).
Because p300 can acetylate Dna2
in vitro, we next examined whether
these two proteins interact in HeLa
whole cell extracts. Endogenous
p300 was co-immunoprecipitated
with antibody against Dna2 and
FEN1, and vice versa, Dna2 was co-
immunoprecipitated with antibody
against p300 and FEN1 (Fig. 1C).
FEN1 and p300 have previously
been shown to co-immunoprecipi-
tate (19).Our results suggest that p300 can forma complexwith
both Dna2 and FEN1, although the exact organization of bind-
ing of these proteins with respect to one another could not be
determined.
Because FEN1 acetylation is increased during UV damage
(19), and yeast dna2 mutants are mildly sensitive to UV, we
analyzed the levels of Ac-Dna2 in HeLa cells exposed to UV
(Fig. 1D). Western blot analysis of immunoprecipitated Dna2
using an antibody against Dna2 showed that a similar amount
of protein was expressed and immunoprecipitated in both
untreated and UV-treated cells. When immunoprecipitated
Dna2 was immunoblotted with an antibody raised against
acetylated lysine residues, we observed an significant increase
in Ac-Dna2 after UV treatment. Increased acetylation of the
immunoprecipitated FEN1onUV treatmentwas also observed,
as reported previously (19).
Effect of Acetylation on hDna2 Nuclease Function—We next
defined the effects of acetylation on the activities of Dna2 in
vitro. Dna2 is a tracking enzyme, whereby it enters the flap at its
5 end and cleaves endonucleolytically while tracking toward
the base, leaving a terminal 5–6-nt flap (23). Although Dna2
can bind directly onto the flap without tracking, the cleavage
activity of Dna2 is dependent on the tracking mode (15). The
FIGURE 1. p300 binds and acetylates Dna2 both in vitro and in vivo. A, 2g of unmodified hDna2 (wtDna2)
and 14C-acetylated in vitro hDna2 (AcDna2) was separated on a 4–15% SDS-polyacrylamide gel. The upper
panel shows theCoomassie stainof the separatedproteins andacts as a loadingcontrol for theunmodifiedand
modified Dna2. The same gel was subsequently exposed to x-ray film for 1 week, and the acetylation status of
Dna2 was analyzed (lower panel). B, 1 ng of purified hDna2 was incubated with 1 ng of recombinant catalytic
domain (amino acids 1284–1673), 1 ng of recombinant catalytic domain (amino acids 965–1810), or 1 ng of
recombinant full-length p300 in a binding assay. The bound proteins were immunoprecipitated (IP) with
antibody against full-length p300, separated by gel electrophoresis, and Dna2 was detected byWestern blot-
ting (IB) with antibody against Dna2. C, HeLa whole cell extracts were used either to immunoprecipitate p300
and immunoblot for p300, Dna2, and FEN1 or immunoprecipitate Dna2 and immunoblot for p300, Dna2, and
FEN1. The co-immunoprecipitatedproteins and theirmolecularweights are indicated in the gel.ML, molecular
weight ladder.D, HeLa whole cell extracts from either untreated or UV-treated cells were used to immunopre-
cipitate Dna2 and immunoblot for Dna2 and acetylated lysines (Ac-K). The proteins associated with the acety-
lated lysines detected by Western blotting were confirmed by stripping the blot and reprobing it with either
anti-Dna2 or anti-FEN1 to confirm the detected protein.
Acetylation of Dna2 by p300
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cleavage patterns of unacetylated Dna2 and Ac-Dna2 were
examined using a 53-nt double flap substrate labeled on the 3
end of the downstream primer. Unacetylated Dna2 cleaved
5–6 nt above the base of the flap, as determined from the
FEN1 cleavage pattern (Fig. 2, lane 11). Ac-Dna2 (Fig. 2, lanes
8–10) showed a 12-fold increase in its cleavage activity com-
pared with the unmodified Dna2 (Fig. 2, lanes 2–4). Signifi-
cantly, Ac-Dna2 was able to make cuts closer to the base of the
flap, and a small percentage of substrates also experienced
cleavage past the base of the flap. The change in the pattern of
Dna2 cleavage suggests an increase in the helicase activity of
Dna2 on modification. Incubation of Dna2 and p300 in the
absence of acetyl Co-A did not result in a difference in the
cleavage pattern compared with the unmodified Dna2 (Fig. 2,
lanes 5–7). This suggests that p300 was not merely stabilizing
the Dna2 to allow more efficient cleavage on the 53-nt flap
substrate, but it was the modification mediated by p300 that
changed the pattern of cleavage by Ac-Dna2.
In addition to the 5–3 endonuclease activity, hDna2 also
exhibits a 3–5 directional nuclease activity, similar to but
more efficient than that of yeast or Caenorhabditis elegans
Dna2 (14). Compared with yeast or C. elegans, the 3–5 nucle-
ase activity of hDna2 on ssDNA is significantly higher than the
5–3 activity.We compared the 3–5 endonuclease activity of
unmodified and acetylated hDna2 using a 30-nt ssDNAblocked
at the 5 end using biotin-conjugated streptavidin to prevent
5–3 cleavage. We observed only a minor (1.5-fold) stimula-
tion in the 3–5 endonuclease activity in Ac-Dna2 (supple-
mental Fig. S1). Notably, the increase in the 3–5 endonuclease
activity resulting from acetylation was significantly lower than
the stimulation of the 5–3 endonuclease activity though the
same active site is proposed to be utilized for both activities
(15).
Effect of Acetylation on hDna2 ATPase and Helicase
Functions—In addition to the nuclease activity, hDna2 also has
a DNA-dependent ATPase function. ATP hydrolysis in the
presence of ssDNA was measured using either unmodified
Dna2 orAc-Dna2. TheATPase activity of hDna2 is significantly
weaker than that of Saccharomyces cerevisiae Dna2 (ScDna2)
(15). However, on modification by p300, Ac-Dna2 showed an
3-fold stimulation of ATPase activity (Fig. 3A). This increase
was independent of the presence of p300 in the absence of
acetyl coenzyme A, demonstrating that the modification on
Dna2 stimulated its ATPase function.
Helicase activity of hDna2, similar to Xenopus Dna2, has
been described as either “moderate” (15) or “extremely mini-
mal” (14) comparedwith that of ScDna2. Using a substrate con-
sisting of a 42-nt oligomer with 24 bp complementary to
M13mp18 and a 5 noncomplementary flap of 18 nt, we
assessed the 5–3 helicase activity of modified Dna2. The
robust nuclease of Dna2 limits the detection of the weak heli-
case. To facilitate accurate helicasemeasurement, the nuclease-
deficient hDna2-D294A mutant protein, described previously,
was used for the helicase assays (15). Helicase function was mea-
sured by the amount of labeled oligonucleotide that was displaced
from the annealed substrate. Helicase activity of Ac-Dna2-D294A
was stimulated by 2-fold (Fig. 3B). The moderate increase in
helicase andATPase activity likely accounts for the 5–3 cleavage
past the base of the flap on a small percentage of 53-nt flap sub-
strates by Ac-Dna2 (Fig. 2).
ScDna2 activity is stimulated by RPA, and in turn it displaces
RPA that is bound on ssDNA flaps (11). Although RPA can
significantly stimulate hDna2 endonuclease function (15), high
levels of RPA were found to inhibit the endonuclease (14). We
assessed the ability of Ac-Dna2 to displace RPA from flap sub-
strates using a 53-nt flap substrate containing pre-bound RPA.
Either unmodified Dna2 or Ac-Dna2 was added to the reaction
and the cleavage pattern ofDna2was observed.Ac-Dna2 exhib-
ited no differences compared with unmodified Dna2 in its abil-
ity to displace RPA (data not shown).
Acetylation of hDna2 Influences Its Binding to DNA
Substrates—Because all of the activities of Dna2were enhanced
by acetylation, we investigated whether there was a correlation
between the binding affinity of Dna2 and acetylation. FEN1
showed significantly reducedDNAbinding activity upon acety-
lation, which likely correlated with its decreased enzymatic
FIGURE 2. Nuclease activity of Dna2 is stimulated upon acetylation by
p300.5–3endonuclease activity. A53-nt flap substrate labeledat the3end
of the downstream primer was used to measure the 5–3 endonuclease
activity of hDna2. Reactions containing 5 fmol of substrate and increasing
concentrations (10, 20, and 50 fmol) of Dna2 alone, Dna2 and p300, and Ac-
Dna2 were incubated for 10 min at 37 °C. A control reaction with 5 fmol of
substrate and 10 fmol of FEN1 was used to identify the base of the flap. The
labeled substrate is depicted above the gel with the asterisk indicating the
site of the 32P label. The substrate alone, 5–3Dna2 cleavage products, FEN1
cleavage product, and cleavages beyond the base of the flap are indicated
beside the gel.
Acetylation of Dna2 by p300
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functions (19). DNA binding efficiency of unmodified and Ac-
Dna2 was measured using a 53-nt double flap substrate similar
to the substrate employed to study the 5–3nuclease activity in
Fig. 2. The unmodified and Ac-Dna2 were allowed to bind
onto the substrate, and the binding affinity was assessed by
electrophoretic mobility gel shift assay. Ac-Dna2 (Fig. 4,
lanes 10–13) showed a significant increase in binding (17-
fold) to a 53-nt flap substrate compared with the unmodified
Dna2 (Fig. 4, lanes 2–5). This binding was apparently not due
to the presence of p300 because p300 in the absence of
acetyl-CoA did not increase the ability of Dna2 binding (Fig.
4, lanes 6–9). These results suggest that the enhanced cata-
lytic activities of Ac-Dna2 derive in part from increased
DNA substrate affinity.
FIGURE 3. Ac-Dna2 shows increased ATPase and helicase activities. A, DNA-dependent ATPase activity of 500 fmol of unmodified and Ac-Dna2 was
analyzed as described under “Experimental Procedures.” The ATPase activity of the unmodified and Ac-Dna2 is plotted in the graph. A control without DNA is
included. B, helicase activity was assayed as described under “Experimental Procedures.” Reactions containing 1 fmol ofM13-HPR partial duplex substrate and
1000 fmolofnuclease-defectivehDna2-D294Aalone (lanes 3and4), hDna2-D294Aandp300 (lanes 5and6), andAc-Dna2-D294A (lanes 7and8)were incubated
for 15 min at 37 °C. Lane 1 represents the boiled substrate, and lane 2 represents the annealed M13-HPR partial duplex substrate. The labeled substrate and
helicase products are indicated at the side of the gel. Positions of the substrate, helicase products, and nuclease products are indicated on the left of the figure.
Acetylation of Dna2 by p300
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DISCUSSION
Our results indicate that p300 regulates the activities of
endonucleases involved in DNA replication and repair to favor
long flap formation. The simultaneous inhibition of FEN1 but
stimulation of Dna2 imply a switching of pathways from one in
which flaps are cleaved and ligated while short, to one in which
flaps grow longer. Inhibition of FEN1 uncouples it from strand
displacement synthesis by the DNA polymerase, allowing flap
displacement without immediate cleavage. Augmentation of
Dna2 activities ensures that the resultant longer flaps are pro-
cessed efficiently and faithfully for proper ligation and may
even increase flap displacement through enhanced helicase
activity. The overall implication is that the cell is intentionally
manipulating flap processing to allow controlled removal of a
greater number of nucleotides, resulting in a longer patch of
resynthesis.
Why would a longer resynthesis patch be advantageous?
DNA polymerase  is a low fidelity polymerase, lacking proof-
reading ability, that lays down the initial RNA/DNA primer in
Okazaki fragments (25). The 3–5 exonuclease activity ofDNA
polymerase , acting at the time of polymerase switching, plays
a significant role in removing the errors caused by polymerase
to maintain genome stability (26). We propose that strand dis-
placement synthesis activity of polymerase , acting during 5
RNA/DNA primer removal, also plays a role in removing mis-
matched base pairs that are laid down by polymerase . More-
over, the displacementwould bemore effective in this process if
it were augmented by the properties of Ac-Dna2 and Ac-FEN1.
We also propose that acetylation of Dna2 and FEN1 would
increase the resynthesis patch during long patch BER, increas-
ing the likelihood of complete damage removal. Consistent
with this idea, the 5-2-deoxyribose 5-phosphate activity of
DNA polymerase  is inhibited on acetylation, suggesting an
influence of acetylation the BER pathway, in which long patch
BER would be favored over short patch BER (6). The overall
effect of acetylation would then have damage repaired more
frequently by a long patch process in which the patch length is
intentionally increased. In support of this proposal, p300 is
known tomodify a number of proteins involved in BER (5, 6, 19,
27, 28), indicating that acetylation is used comprehensively to
regulate this pathway.
Why does p300 exert this regulation? The local chromatin
environment influences the efficiency of DNA replication and
repair. DNA is susceptible to more damage in euchromatin
compared with heterochromatin (29), yet the integrity of active
chromatin is most important to preserve. We suggest that the
cell utilizes the chromatin-associated histone acetyltransferase
p300 in active chromatin locally to improve the fidelity of DNA
base excision repair and nucleotide excision repair by length-
ening resynthesis. DNA replication through active chromatin
would also be more accurate because the longer resynthesis
patch would ensure complete removal of the RNA/DNA
primer. Alternatively, or in addition, the transient long flap
could serve as a signal to recruit DNA replication or repair
proteins so that they would be present at high concentration in
the region. The likelihood that the long flap pathway, involving
Dna2, is intentionally induced also provides an answer to the
longstanding puzzle of why the Dna2 pathway has evolved. The
current belief is that it catches the small fraction of flapsmissed
by FEN1 while they are short (12). However, its main purpose
may be as an extreme accuracy alternative to normal flap
processing.
Consistent with the idea that p300 directs location-depend-
ent regulation, acetylation of BER proteins alters their activity
and subcellular localization differentially (5, 6, 19, 27, 28). DNA
lesions are less accessible to DNA repair complexes in chroma-
tin than in free DNA. In fact, chromatin-remodeling enzymes
such as p300 play a significant role in “opening up” the chroma-
tin around DNA lesions. UV irradiation causes an increase in
the activity of histone acetyltransferases and a decrease in the
activity of histone deacetylases (30). As discussed earlier, PCNA
has been implicated in recruiting p300 to DNA damage sites,
and p300 in turn acts as a recruiting factor for additional repair
complexes (2, 31). Recruitment of p300 to damage sites by
PCNAmight promote the observed acetylation of relevant pro-
teins. All of these observations are consistent with the existence
of a general mechanism for regulation of DNA replication and
repair by acetylation. We believe that the long flap induction
mechanism described here is part of this overall effort by the
cell to protect genetic information in the busy environment of
active chromatin.
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FIGURE 4. Increased binding efficiency of Ac-Dna2. Substrate binding effi-
ciency ofDna2 andAc-Dna2was studiedusing electromobility gel shift assay.
Five fmol of 53-nt substrate was incubated with increasing concentrations
(10, 20, and 50 fmol) of Dna2 alone, Dna2 and p300, and Ac-Dna2, and the
reactionswere incubated for 10min at room temperature and separated on a
5% polyacrylamide gel. The labeled substrate is depicted above the gel with
the asterisk indicating the site of the 32P label. The substrate alone and com-
plexes containing Dna2-bound substrate are indicated beside the gel at the
right.
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